The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing

Authors

Rosario Diaz-Gonzalez, Instituto de Parasitologı´a y Biomedicina
F. Matthew Kuhlmann, Washington University School of Medicine in St. LouisFollow
Cristina Galan-Rodriguez, New York University School of Medicine
Manuel Saldivia, Instituto de Parasitologı´a y Biomedicina
Caitlin E. Karver, Northeastern University
Ana Rodriguez, New York University School of Medicine
Stephen M. Beverley, Washington University School of Medicine in St. LouisFollow
Miguel Navarro, Instituto de Parasitologı´a y Biomedicina
Michael P. Pollastri, Northeastern University

Journal

PLoS Neglected Tropical Diseases

Publication Date

2011

Volume

5

Issue

8

Inclusive Pages

e1297

Document Type

Open Access Publication

DOI

10.1371/journal.pntd.0001297

Rights and Permissions

Diaz-Gonzalez R, Kuhlmann FM, Galan-Rodriguez C, da Silva LM, Saldivia M, et al. 2011 The Susceptibility of Trypanosomatid Pathogens to PI3/mTOR Kinase Inhibitors Affords a New Opportunity for Drug Repurposing. PLoS Negl Trop Dis 5(8): e1297. doi:10.1371/journal.pntd.0001297

Recommended Citation

Diaz-Gonzalez, Rosario; Kuhlmann, F. Matthew; Galan-Rodriguez, Cristina; Saldivia, Manuel; Karver, Caitlin E.; Rodriguez, Ana; Beverley, Stephen M.; Navarro, Miguel; and Pollastri, Michael P., "The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing." PLoS Neglected Tropical Diseases. 5, 8. e1297. (2011).
https://digitalcommons.wustl.edu/open_access_pubs/402